{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:35:08Z","timestamp":1773700508801,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1093\/intimm\/11.6.925","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:35:13Z","timestamp":1027722913000},"page":"925-931","source":"Crossref","is-referenced-by-count":48,"title":["Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease"],"prefix":"10.1093","volume":"11","author":[{"given":"Keiko","family":"Miwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigekazu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,6]]},"reference":[{"key":"key\n\t\t\t\t20170710080725_R1","doi-asserted-by":"crossref","unstructured":"K\u00e4gi, D., Vagnaux, F., Ledermann, B., B\u00fcrki, K., Deraetere, V., Nagata, S., Hengartner, H. and Golstein, P. 1994. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science265:528.","DOI":"10.1126\/science.7518614"},{"key":"key\n\t\t\t\t20170710080725_R2","doi-asserted-by":"crossref","unstructured":"Kojima, H., Shinohara, N., Hanaoka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., Shinkai, Y., Alt, F. W., Matsuzawa, A., Yonehara, S. and Takayama, H. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity1:357.","DOI":"10.1016\/1074-7613(94)90066-3"},{"key":"key\n\t\t\t\t20170710080725_R3","doi-asserted-by":"crossref","unstructured":"Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature370:650.","DOI":"10.1038\/370650a0"},{"key":"key\n\t\t\t\t20170710080725_R4","doi-asserted-by":"crossref","unstructured":"Kondo, T., Suda, T., Fukuyama, H., Adachi, M. and Nagata, S. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med.3:409.","DOI":"10.1038\/nm0497-409"},{"key":"key\n\t\t\t\t20170710080725_R5","doi-asserted-by":"crossref","unstructured":"Ferrara, J. L. and Deeg, H. J. 1991. Graft-versus-host disease. N. Engl. J. Med.324:667.","DOI":"10.1056\/NEJM199103073241005"},{"key":"key\n\t\t\t\t20170710080725_R6","unstructured":"Appelbaum, F. R. 1997 Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). LeukemiaS15."},{"key":"key\n\t\t\t\t20170710080725_R7","doi-asserted-by":"crossref","unstructured":"Theofilopoulos, A. N., Balderas, R. S., Gozes, Y., Aguado, M. T., Hang, L., Morrow, P. R. and Dixon, F. J. 1985. Association of lpr gene with graft-vs.-host disease-like syndrome. J. Exp. Med.162:1.","DOI":"10.1084\/jem.162.1.1"},{"key":"key\n\t\t\t\t20170710080725_R8","doi-asserted-by":"crossref","unstructured":"Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J.14:12.","DOI":"10.1002\/j.1460-2075.1995.tb06970.x"},{"key":"key\n\t\t\t\t20170710080725_R9","doi-asserted-by":"crossref","unstructured":"Braun, M. Y., Lowin, B., French, L., Acha, O. H. and Tschopp, J. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med.183:657.","DOI":"10.1084\/jem.183.2.657"},{"key":"key\n\t\t\t\t20170710080725_R10","doi-asserted-by":"crossref","unstructured":"Baker, M. B., Altman, N. H., Podack, E. R. and Levy, R. B. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med.183:2645.","DOI":"10.1084\/jem.183.6.2645"},{"key":"key\n\t\t\t\t20170710080725_R11","doi-asserted-by":"crossref","unstructured":"Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S. and Suda, T. 1998. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand [in process citation]. Nat. Med.4:1287.","DOI":"10.1038\/3276"},{"key":"key\n\t\t\t\t20170710080725_R12","doi-asserted-by":"crossref","unstructured":"Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell66:233.","DOI":"10.1016\/0092-8674(91)90614-5"},{"key":"key\n\t\t\t\t20170710080725_R13","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata, S. 1996. Fas ligand in human serum. Nat. Med.2:317.","DOI":"10.1038\/nm0396-317"},{"key":"key\n\t\t\t\t20170710080725_R14","doi-asserted-by":"crossref","unstructured":"Suda, T. and Nagata, S. 1994. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med.179:873.","DOI":"10.1084\/jem.179.3.873"},{"key":"key\n\t\t\t\t20170710080725_R15","doi-asserted-by":"crossref","unstructured":"Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol.154:3806.","DOI":"10.4049\/jimmunol.154.8.3806"},{"key":"key\n\t\t\t\t20170710080725_R16","doi-asserted-by":"crossref","unstructured":"Suda, T., Tanaka, M., Miwa, K. and Nagata, S. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol.157:3918.","DOI":"10.4049\/jimmunol.157.9.3918"},{"key":"key\n\t\t\t\t20170710080725_R17","doi-asserted-by":"crossref","unstructured":"Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell76:969.","DOI":"10.1016\/0092-8674(94)90375-1"},{"key":"key\n\t\t\t\t20170710080725_R18","doi-asserted-by":"crossref","unstructured":"Russell, J. H., Rush, B., Weaver, C. and Wang, R. 1993. Mature T cells of autoimmune lpr\/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl Acad. Sci. USA90:4409.","DOI":"10.1073\/pnas.90.10.4409"},{"key":"key\n\t\t\t\t20170710080725_R19","doi-asserted-by":"crossref","unstructured":"Alderson, M. R., Tough, T. W., Davis, S. T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med.181:71.","DOI":"10.1084\/jem.181.1.71"},{"key":"key\n\t\t\t\t20170710080725_R20","doi-asserted-by":"crossref","unstructured":"Ettinger, R., Panka, D. J., Wang, J. K., Stanger, B. Z., Ju, S. T. and Marshak, R. A. 1995. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J. Immunol.154:4302.","DOI":"10.4049\/jimmunol.154.9.4302"},{"key":"key\n\t\t\t\t20170710080725_R21","doi-asserted-by":"crossref","unstructured":"Suda, T., Hashimoto, H., Tanaka, M., Ochi, T. and Nagata, S. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med.186:2045.","DOI":"10.1084\/jem.186.12.2045"},{"key":"key\n\t\t\t\t20170710080725_R22","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Itai, T., Adachi, M. and Nagata, S. 1998. Downregulation of Fas ligand by shedding. Nat. Med.4:31.","DOI":"10.1038\/nm0198-031"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/11\/6\/925\/18317992\/110925.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T04:05:47Z","timestamp":1682222747000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article-lookup\/doi\/10.1093\/intimm\/11.6.925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,6]]},"published-print":{"date-parts":[[1999,6]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/11.6.925","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}